News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Artem Oganesyan: Thank You SOHO for Selecting Our Work for the Young Investigator Award
Artem Oganesyan/LinkedIn
Sep 4, 2025, 04:32

Artem Oganesyan: Thank You SOHO for Selecting Our Work for the Young Investigator Award

Artem Oganesyan, Resident Physician at Jefferson Abington Hospital, shared a post on LinkedIn about a paper published in Clinical Lymphoma, Myeloma and Leukemia:

“Our meta-analysis of RCTs is presented at SOHO2025.

We showed clinical efficacy and safety of Pembrolizumab or Nivolumab (two most commonly used PD-1 inhibitors) for frontline treatment of classical Hodgkin Lymphoma in patients with advanced disease or unfit for standard treatment (chemotherapy).

Thank you Society of Hematologic Oncology for selecting our work for the Young Investigator Award.”

Title: HL-850: Clinical Efficacy and Safety of Pembrolizumab and Nivolumab in Frontline Treatment for Classical Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Authors: Artem Oganesyan, Andrew Gregory, Mark Gregory, Vahe Khachatryan, Liana Hayrapetyan, Deivid Badalian, Abhay Aradya, Aheed Javaid, Yervand Hakobyan

Read the full article.

SOHO

More posts featuring Artem Oganesyan on OncoDaily.

Abhay Aradya Aheed Javaid Andrew Gregory Artem Oganesyan cancer Clinical Lymphoma Deivid Badalian Hodgkin lymphoma Liana Hayrapetyan Mark Gregory Myeloma and Leukemia nivolumab OncoDaily Oncology pembrolizumab Society of Hematologic Oncology SOHO2025 Vahe Khachatryan Yervand Hakobyan Young Investigator Award
Special Coverage
Science
Sep 4, 2025, 04:32
Artem Oganesyan: Thank You SOHO for Selecting Our Work for the Young Investigator Award
Voices
Sep 4, 2025, 04:07
Sustainable Cancer Care Starts with Capacity Development - City Cancer Challenge
Opinion
Sep 4, 2025, 03:50
What’s the Value of a Course if It Doesn’t Shape the Way You Practice? – European School of Oncology
Science
Sep 4, 2025, 03:26
Svetlana Nikic: Can Concordance Between Liquid and Tissue Biopsies Change Outcomes?
Societies
Sep 4, 2025, 03:12
Join the UNGA80 Side Event on Childhood Cancer - SIOP
Societies
Sep 4, 2025, 03:01
Excited to Announce the ASCOQLTY25 Featured Voices – ASCO
Voices
Sep 4, 2025, 00:02
Chris Poulios: Live from the Vision Europe 2030 Meeting of EAPM
Societies
Sep 3, 2025, 23:42
The SIOG 2025 Annual Conference: A Milestone Congress Celebrating 25 years of SIOG
Voices
Sep 3, 2025, 23:15
Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025
Insight
Sep 3, 2025, 23:00
Eduardo Bruera: Addressing Psychosocial Needs in Young Adult Cancer Patients
Insight
Sep 3, 2025, 22:35
Raising Awareness for Head and Neck Cancer - European Cancer Organisation
Insight
Sep 3, 2025, 22:09
Felipe Couñago: A Timely and Inspiring Contribution to Neuro-Oncology